ClinicalTrials.Veeva

Menu

Effects of AffronEye®/ Crocuvis+® on Dry Eye Syndrome

U

University of Alicante

Status

Begins enrollment in 2 months

Conditions

Dry Eye Syndrome

Treatments

Dietary Supplement: Saffron extract (Crocus sativus)
Dietary Supplement: Placebo

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT06240364
PHARMACTIVE1-24I

Details and patient eligibility

About

Previous research has demonstrated the effectiveness of AFFRONEYE® / CROCUVIS+® dietary supplement, based on saffron extract, in the proper functioning of visual health, for example, against the development of glaucoma. The main objective of this study is to compare the results of clinical tests that evaluate signs and symptoms for the diagnosis of dry eye, between two groups (some that take the dietary supplement and others a placebo), in a sample of university workers and students who suffer from dry eye.

Enrollment

204 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Have dry eye according to the diagnostic criteria established by the Tear Film and Ocular Surface Society (TFOS) Dry Eye Workshop (DEWS).

Exclusion criteria

  • Pathology of the anterior ocular surface under treatment (such as conjunctivitis, keratitis, among others).
  • Take any type of dietary supplements, with or without botanical components in the last month.
  • Pregnancy or breastfeeding (also excludes recent pregnancy within the last 3 months) and women planning to become pregnant.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

204 participants in 2 patient groups, including a placebo group

Saffron extract (Crocus sativus)
Experimental group
Description:
Daily intake of one tablet for 84 days.
Treatment:
Dietary Supplement: Saffron extract (Crocus sativus)
Placebo
Placebo Comparator group
Description:
Daily intake of one tablet for 84 days. This tablet is organoleptically indistinguishable from the experimental tablet.
Treatment:
Dietary Supplement: Placebo

Trial contacts and locations

1

Loading...

Central trial contact

María de Mar Seguí Crespo, PhD; Elena Ronda Pérez, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems